APA

Horn M., Wolf P., Wulf H. C., Warloe T., Fritsch C., Rhodes L. E., Kaufmann R., De Rie M., Legat F. J., Stender I. M., Solér A. M., Wennberg A., Wong G. A. E. & Larkö O. (20040311). Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. : The British journal of dermatology.

Chicago

Horn M, Wolf P, Wulf H C, Warloe T, Fritsch C, Rhodes L E, Kaufmann R, De Rie M, Legat F J, Stender I M, Solér A M, Wennberg A-M, Wong G A E and Larkö O. 20040311. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. : The British journal of dermatology.

Harvard

Horn M., Wolf P., Wulf H. C., Warloe T., Fritsch C., Rhodes L. E., Kaufmann R., De Rie M., Legat F. J., Stender I. M., Solér A. M., Wennberg A., Wong G. A. E. and Larkö O. (20040311). Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. : The British journal of dermatology.

MLA

Horn M, Wolf P, Wulf H C, Warloe T, Fritsch C, Rhodes L E, Kaufmann R, De Rie M, Legat F J, Stender I M, Solér A M, Wennberg A-M, Wong G A E and Larkö O. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. : The British journal of dermatology. 20040311.